Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146124 | SCV000193341 | pathogenic | Neonatal insulin-dependent diabetes mellitus | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226652 | SCV002505652 | likely pathogenic | Type 2 diabetes mellitus | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which is responsive to oral sulfonylureas. rs193929356 (c.989A>G, p.Y330C) of KCNJ11 is associated with early onset Type I Diabetes Mellitus. | |
Labcorp Genetics |
RCV003556059 | SCV004295355 | pathogenic | not provided | 2023-06-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNJ11 protein function. ClinVar contains an entry for this variant (Variation ID: 21204). This missense change has been observed in individual(s) with early onset diabetes (PMID: 15448107, 29361385, 32792356). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 330 of the KCNJ11 protein (p.Tyr330Cys). |
Gene |
RCV000020361 | SCV000040745 | not provided | Permanent neonatal diabetes mellitus | no assertion provided | literature only |